Coverage
-
October 15, 2021
A Missouri federal judge has dismissed design defect claims against Arena Pharmaceuticals over its weight loss medication Belviq, but the drugmaker couldn't shake allegations that its negligence and inadequate warnings caused a woman's breast cancer.
1 other articles on this case.
View all »